The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJust Group Regulatory News (JUST)

Share Price Information for Just Group (JUST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 103.00
Bid: 103.00
Ask: 103.40
Change: 0.00 (0.00%)
Spread: 0.40 (0.388%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 103.00
JUST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter New Business Results

3 Nov 2016 07:00

RNS Number : 1964O
JRP Group PLC
03 November 2016
 

 

 

NEWS RELEASE www.jrpgroup.com

3 November 2016

 

JRP GROUP PLC

NEW BUSINESS UPDATE FOR THE PERIOD ENDED 30 SEPTEMBER 2016

DELIVERING SUSTAINABLE PROFITABLE GROWTH

 

 

JRP Group plc ("JRP", "the Group") announces its new business update for the period ended 30 September 2016.

 

Highlights

 

· Total sales up 21% in the nine months ended 30 September 2016 on a pro forma basis

· Guaranteed Income for Life (GIfL) sales up 12% to £603.8m on a pro forma basis

· Defined Benefit De-risking (DB) sales of £578.4m, an increase of 29% on a pro forma basis

· Lifetime Mortgage (LTM) advances of £464.7m, an increase of 27% on a pro forma basis

· Solvency II SCR coverage ratio at 30 June 2016 would have risen to an estimated 151%, had the recently issued £250m in Tier 2 debt proceeds been in place

 

· IFRS new business margin guidance of 6% reaffirmed for the full calendar year

 

 

Rodney Cook, Group Chief Executive, said:

"The benefits of the merger to the JRP Group continue to be demonstrated through both strong sales growth announced today and favourable margin development announced in September. Total sales were up 21% on a pro forma basis in the nine months, and 54% in the quarter ended September. We remain comfortable with our guidance of a 6% IFRS new business margin for the full calendar year and this represents levels last achieved before the pension freedoms were announced in 2014. As we disclosed at interims, we are ahead of schedule in delivering the synergy benefits of at least £45m per annum with the full run-rate being achieved by 2018.

The strong recovery of our business is demonstrated by our Retirement Income sales of £640.8m in the three months ended September. This compares to sales of £619.2m in the preceding six months which were impacted by a slow start to the year for Defined Benefit De-risking sales. Mortgage advances have continued to be strong, and are still ahead of our 25% of Retirement Income target for the year to date.

We are successfully adapting our business model to the new capital environment and remain confident of achieving attractive internal rates of return on new business once the synergy benefits are fully realised, well in excess of the recent cost of debt and our weighted average cost of capital. The combination of increased margins, strong synergy delivery and sound capital position confirm the sustainable growth which our business model can deliver.

We are pleased with the support we have received from institutional investors to our recent £250m Tier 2 capital transaction and this demonstrates their confidence in the Group's business model and its prospects."

 

 

JRP pro forma

9 months

9 months

Change

3 months

3 months

Change

 

to

to

 

to

to

 

 

30/9/16

30/9/15

 

30/9/16

30/9/15

 

 

£m

£m

%

£m

£m

%

Defined Benefit De-risking

578.4

449.7

29

414.0

127.6

224

Guaranteed Income for Life

603.8

540.2

12

206.7

200.6

3

Care Plans

77.8

62.3

25

20.1

21.7

-7

Retirement Income sales

1,260.0

1,052.2

20

640.8

349.9

83

Drawdown

14.8

17.0

-13

9.4

3.6

161

Total Retirement sales

1,274.8

1,069.2

19

650.2

353.5

84

Protection

3.8

3.1

23

1.5

1.0

50

Lifetime mortgage loans advanced

464.7

366.7

27

142.9

161.9

-12

Total new business sales

1,743.3

1,439.0

21

794.6

516.4

54

 

 

JRP Statutory

15 months

15 months

Change

 

to

to

 

 

30/9/16

30/9/15

 

 

£m

£m

%

Defined Benefit De-risking

1,279.6

712.5

80

Guaranteed Income for Life

798.6

610.6

31

Care Plans

78.1

17.8

339

Retirement Income sales

2,156.3

1,340.9

61

Drawdown

22.0

52.3

-58

Total Retirement sales

2,178.3

1,393.2

56

Protection

2.5

0.0

-

Lifetime mortgage loans advanced

635.2

422.5

50

Total new business sales

2,816.0

1,815.7

55

 

 

Notes

The merger of Just Retirement and Partnership is required for accounting purposes to be treated as an acquisition by Just Retirement of Partnership with an effective date of the beginning of April 2016. Accordingly the statutory information includes 15 months of Just Retirement and six months results of Partnership. Just Retirement Group plc (renamed JRP Group plc) changed its year end to 31 December and consequently its next statutory reporting period will be for the 18 months to December 2016. As a consequence pro-forma sales data as though the merger took place at the beginning of January 2015 have been presented to give the market an understanding of the business of the merged Group.

 

 

 

Enquiries

 

Investors / Analysts

 

James Pearce, Group Director of Corporate Finance and Investor Relations

 

Telephone: +44 (0) 7715 085 099

james.pearce@justretirement.com

 

Media

 

Stephen Lowe, Group Communications Director

 

 

Telephone: +44 (0) 1737 827 301

press.office@justretirement.com

 

Temple Bar Advisory

Alex Child-Villiers

William Barker

Telephone: +44 (0) 20 7002 1080

 

 

A copy of this announcement will be available on the Group's website www.jrpgroup.com

 

JRP GROUP PLC

GROUP COMMUNICATIONS

Vale House, Roebuck Close

Bancroft Road, Reigate

Surrey RH2 7RU

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTFLLLBQFFXFBX
Date   Source Headline
25th Apr 202410:04 amRNSDirector/PDMR Shareholding
12th Apr 202410:00 amRNSDirector/PDMR Shareholding
2nd Apr 20245:20 pmRNSDirector/PDMR Shareholding
26th Mar 20244:09 pmRNSHolding(s) in Company
26th Mar 20244:08 pmRNSHolding(s) in Company
26th Mar 20243:41 pmRNSAnnual Report and Accounts and Notice of AGM
8th Mar 20247:00 amRNSResults for the year ended 31 December 2023
7th Mar 20244:00 pmRNSHolding(s) in Company
6th Mar 20244:00 pmRNSHolding(s) in Company
4th Mar 20244:30 pmRNSHolding(s) in Company
5th Feb 20245:00 pmRNSHolding(s) in Company
31st Jan 20243:30 pmRNSHolding(s) in Company
26th Jan 20241:49 pmRNSHolding(s) in Company
25th Jan 20245:30 pmRNSDirector Declaration
22nd Jan 20244:43 pmRNSHolding(s) in Company
18th Jan 20244:55 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSBUSINESS UPDATE FOR YEAR ENDED 31 DECEMBER 2023
17th Jan 20244:12 pmRNSHolding(s) in Company
12th Jan 20243:01 pmRNSHolding(s) in Company
10th Jan 20241:31 pmRNSHolding(s) in Company
4th Jan 20244:25 pmRNSHolding(s) in Company
1st Dec 202311:32 amRNSBlock listing Interim Review
28th Nov 20233:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20233:04 pmRNSDirectorate Change
13th Oct 202310:41 amRNSDirectorate Change
28th Sep 202310:13 amRNSDirector/PDMR Shareholding
16th Aug 20232:04 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS ENDED 30/6/2023
20th Jul 20233:00 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSBusiness update for the six months to 30 June 2023
12th Jul 202310:34 amRNSDirectorate Change
11th Jul 20237:00 amRNSIFRS 17 FY 2022 and H1 22 restatement
6th Jul 20237:00 amRNSDirectorate Change
28th Jun 20239:36 amRNSHolding(s) in Company
1st Jun 202310:00 amRNSBlock listing Interim Review
25th May 20234:00 pmRNSHolding(s) in Company
9th May 20231:02 pmRNSResult of AGM
3rd May 20239:30 amRNSDirectorate Change
13th Apr 202312:05 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:05 pmRNSDirector/PDMR Shareholding
24th Mar 20234:50 pmRNSAnnual Financial Report and Notice of AGM
24th Mar 202311:06 amRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSResults for the year ended 31 December 2022
1st Mar 20231:08 pmRNSDirectorate Change
6th Feb 20237:00 amRNSIFRS 17 UPDATE
26th Jan 20237:00 amRNSBUSINESS UPDATE FOR THE YEAR ENDED 31 DEC 2022
5th Jan 202310:19 amRNSDirectorate Change
9th Dec 202212:15 pmRNSDirector/PDMR Shareholding
1st Dec 20221:32 pmRNSBlock listing Interim Review
11th Nov 202210:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.